| Kenneth James Kroger, MD | |
|
11815 Education Street, Auburn, CA 95602-2410 | |
| (530) 888-4500 | |
| Not Available |
| Full Name | Kenneth James Kroger |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 11815 Education Street, Auburn, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548378136 | NPI | - | NPPES |
| 00G738640 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G73864 (California) | Primary |
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Due to previous evidence suggesting that zinc deficiencies can lead to complications along with an impaired antiviral response, a group of international researchers has undertaken a prospective observational study to investigate this association further.
How can counting cancer cells in the blood make a difference in treatment? Can a potent hormone that fuels some breast cancers be used to fire back against the disease? These critical questions are being answered via innovative laboratory and clinical research underway at Georgetown Lombardi Comprehensive Cancer Center. A renowned pharmacologist who discovered a leading treatment for cancer and a physician treating patients in cutting edge clinical trials will discuss these and other life-enhancing discoveries during Doctors Speak Out, a series of conversations with physicians and researchers on today's most pressing health issues.
NeoChord, Inc., a venture-backed, Minneapolis-based medical technology company, announced today that it has enrolled the first patient in its European clinical trial. The trial, known as TACT (transapical artificial chordae tendineae) is being conducted in Germany, Denmark, Czech Republic and Norway.
InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced that patient enrollment was recently completed in the company's Phase 1/2 clinical trial of ISV-303, a novel compound being developed to reduce the pain and inflammation associated with ocular surgery.
A protein that's common throughout the body plays a key role in regulating glucose levels, says new research conducted in the Cell Signal Unit at the Okinawa Institute of Science and Technology Graduate University and Riken Center of Integrative Medical Sciences.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth James Kroger, MD 2100 Powell St, Suite 920, Emeryville, CA 94608-1826 Ph: (510) 350-2600 | Kenneth James Kroger, MD 11815 Education Street, Auburn, CA 95602-2410 Ph: (530) 888-4500 |
News Archive
Due to previous evidence suggesting that zinc deficiencies can lead to complications along with an impaired antiviral response, a group of international researchers has undertaken a prospective observational study to investigate this association further.
How can counting cancer cells in the blood make a difference in treatment? Can a potent hormone that fuels some breast cancers be used to fire back against the disease? These critical questions are being answered via innovative laboratory and clinical research underway at Georgetown Lombardi Comprehensive Cancer Center. A renowned pharmacologist who discovered a leading treatment for cancer and a physician treating patients in cutting edge clinical trials will discuss these and other life-enhancing discoveries during Doctors Speak Out, a series of conversations with physicians and researchers on today's most pressing health issues.
NeoChord, Inc., a venture-backed, Minneapolis-based medical technology company, announced today that it has enrolled the first patient in its European clinical trial. The trial, known as TACT (transapical artificial chordae tendineae) is being conducted in Germany, Denmark, Czech Republic and Norway.
InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced that patient enrollment was recently completed in the company's Phase 1/2 clinical trial of ISV-303, a novel compound being developed to reduce the pain and inflammation associated with ocular surgery.
A protein that's common throughout the body plays a key role in regulating glucose levels, says new research conducted in the Cell Signal Unit at the Okinawa Institute of Science and Technology Graduate University and Riken Center of Integrative Medical Sciences.
› Verified 7 days ago
John R. Bauer, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11815 Education Street, Auburn, CA 95602 Phone: 530-888-4500 | |
Brian B. Stamper, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11815 Education Street, Auburn, CA 95602 Phone: 530-888-4500 | |
Ian L. Solari, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11795 Education St Ste 201, Auburn, CA 95602 Phone: 530-889-7470 Fax: 530-889-7471 | |
Daniel E Carter, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11815 Education St, Auburn, CA 95602 Phone: 530-888-4500 | |
Kevin Arnold Owens, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11815 Education St, Auburn, CA 95602 Phone: 530-888-4500 | |
Dr. Graham Torquil Billingham, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 11760 Atwood Rd, Suite 5, Auburn, CA 95603 Phone: 530-328-1348 Fax: 530-889-8742 |